These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-000507-17||Effectiveness of rivastigmine treatment in post-stroke patients with right brain damage and unilateral spatial neglect||not-yet-due|
|Ongoing||2005-004498-31||Behaviour and cognition in Alzheimer s disease patients treated with the NMDA receptor antagonist memantine collelation with the apoptotic mechanisms.||not-yet-due|
|Ongoing||2005-005859-18||EFFECT OF MEMANTINE TREATMENT ON BRAIN FUNCTION AND MORPHOLOGICAL STRUCTURE IN PATIENTS WITH MODERATE TO SEVERE PATIENTS WITH ALZHEIMER S DISEASE A STRUCTURAL MR AND FMRI STUDY||not-yet-due|
|Ongoing||2006-004435-30||Protocol of study for the evaluation of the efficacy of rivastigmine on cognitive and behavioural disorders, following traumatic brain injury TBI in chronic patients.||not-yet-due|
|Ongoing||2009-017317-30||Investigating the neuroprotective effect of Donepezil in patients affected by Alzheimer disease: a 12 month longitudinal analysis of the peripheral levels of neurotrophins and inflammatory factors in ...||not-yet-due|
|Ongoing||2012-000287-17||PROMOTION OF FUNCTIONAL RESTORATION THROUGH PHARMACOLOGICAL MODULATION OF BRAIN PLASTICITY WITH AMINOPYRIDINE IN PATIENTS WITH MULTIPLE SCLEROSIS STUDIED BY FUNCTIONAL MRI||not-yet-due|
|Ongoing||2012-001218-40||EFFICACY OF ROTIGOTINE ON GAIT PERFORMANCE OF PARKINSONIAN PATIENTS||not-yet-due|
|Ongoing||2015-002965-43||Dopaminergic therapy for Alzheimer's disease patients||not-yet-due|